Karyopharm Therapeutics (KPTI) Insider Trading & Ownership $4.62 +0.01 (+0.22%) Closing price 07/3/2025 02:45 PM EasternExtended Trading$4.49 -0.13 (-2.81%) As of 07/3/2025 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Karyopharm Therapeutics (NASDAQ:KPTI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.98%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$12.15K Get KPTI Insider Trade Alerts Want to know when executives and insiders are buying or selling Karyopharm Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KPTI Insider Buying and Selling by Quarter Karyopharm Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/23/2025Reshma RangwalaEVPSell419$6.17$2,585.23 10/4/2024Richard A PaulsonCEOSell240$13.20$3,168.00 8/6/2024Richard A PaulsonCEOSell240$13.95$3,348.00 7/30/2024Stuart PoultonEVPSell192$15.90$3,052.80 7/5/2024Richard A PaulsonCEOSell241$12.75$3,072.75 (Data available from 1/1/2013 forward) KPTI Insider Trading Activity - Frequently Asked Questions Who is on Karyopharm Therapeutics' Insider Roster? The list of insiders at Karyopharm Therapeutics includes Deepika Pakianathan, Garen G Bohlin, Michael Mano, Michael Mason, Reshma Rangwala, Richard A Paulson, Sohanya Roshan Cheng, Stephen Mitchener, and Stuart Poulton. Learn more on insiders at KPTI. What percentage of Karyopharm Therapeutics stock is owned by insiders? 2.98% of Karyopharm Therapeutics stock is owned by insiders. Learn more on KPTI's insider holdings. Which Karyopharm Therapeutics insiders have been buying company stock? The following insider purchased KPTI shares in the last 24 months: Garen G Bohlin ($50,178.60). How much insider buying is happening at Karyopharm Therapeutics? Insiders have purchased a total of 2,742 KPTI shares in the last 24 months for a total of $50,178.60 bought. Which Karyopharm Therapeutics insiders have been selling company stock? The following insiders have sold KPTI shares in the last 24 months: Deepika Pakianathan ($1,224,177.30), Michael Mano ($25,016.10), Michael Mason ($52,219.50), Reshma Rangwala ($28,840.03), Richard A Paulson ($147,394.50), Sohanya Roshan Cheng ($9,855.30), and Stuart Poulton ($15,632.85). How much insider selling is happening at Karyopharm Therapeutics? Insiders have sold a total of 100,225 Karyopharm Therapeutics shares in the last 24 months for a total of $1,503,135.58 sold. More Insider Trading Tools from MarketBeat Related Companies Journey Medical Insider Buying INmune Bio Insider Buying Kyverna Therapeutics Insider Buying Actuate Therapeutics Insider Buying Alector Insider Buying Lyell Immunopharma Insider Buying Lexeo Therapeutics Insider Buying Fate Therapeutics Insider Buying Black Diamond Therapeutics Insider Buying Vaxart Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest This page (NASDAQ:KPTI) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Karyopharm Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Karyopharm Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KPTI Stock Alerts